Invesco LLC (Illinois)’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.19M Sell
4,544
-33
-0.7% -$8.46K 0.37% 62
2026
Q2
$1.15M Buy
4,577
+1,067
+30% +$230K 0.36% 62
2026
Q1
$763K Buy
3,510
+156
+5% +$34.6K 0.27% 76
2025
Q4
$766K Buy
3,354
+1,499
+81% +$341K 0.26% 73
2025
Q3
$430K Buy
1,855
+224
+14% +$45.6K 0.15% 96
2025
Q2
$303K Buy
1,631
+605
+59% +$112K 0.11% 113
2025
Q1
$215K Buy
+1,026
New +$199K 0.09% 125
2024
Q4
– Sell
-1,035
Closed -$204K – 154
2024
Q3
$204K Buy
+1,035
New +$193K 0.08% 152
2024
Q1
– Sell
-1,334
Closed -$207K – 156
2023
Q4
$207K Sell
1,334
-100
-7% -$14.6K 0.1% 154
2023
Q3
$214K Buy
+1,434
New +$211K 0.11% 144

Other funds holding ABBV

Invesco LLC (Illinois)'s ABBV Position: Q3 2026 in Review

Invesco LLC (Illinois) reduced its AbbVie (ABBV) stake by 0.72% in Q3 2026, selling an estimated $8.46K and leaving 4,544 shares worth $1.19M. The position accounts for 0.37% of the portfolio, ranked #62.

Invesco LLC (Illinois) first reported a position in ABBV in Q3 2023 and has held it in 10 quarters since. 4,281 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Invesco LLC (Illinois) held 4,544 shares of AbbVie worth $1.19M as of Q3 2026.
  • Invesco LLC (Illinois) sold 33 AbbVie shares in Q3 2026, an estimated $8.46K.
  • AbbVie made up 0.37% of Invesco LLC (Illinois)'s portfolio in Q3 2026, its #62 holding.
  • Invesco LLC (Illinois) first reported a position in AbbVie in Q3 2023 and has held it in 10 quarters since.
  • 4,281 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Invesco LLC (Illinois)'s 13F filing for Q3 2026, filed 20 Oct 2026.